Marfan Syndrome is a rare genetic disorder that affects connective tissue. It requires a multi-faceted treatment approach focused on managing symptoms and preventing complications. In India, the treatment cost of this condition starts from Rs. 1,91,000, which depends on the types of treatment and medical care services.
While a complete cure for Marfan Syndrome is still under research, several therapies can significantly improve quality of life. Medications such as beta blockers are commonly prescribed to lower blood pressure and reduce stress on the aorta, which is often impacted by the condition. These treatments help manage symptoms and prevent complications.
In severe cases of Marfan Syndrome, doctors often recommend Bentall surgery, which has now become a commonly performed procedure for managing this condition. In India, the cost of Bentall surgery typically ranges from Rs. 10,50,000 to Rs. 13,90,000. Other treatment options, such as aortic aneurysm repair, may cost between Rs. 6,00,000 and Rs. 12,00,000.
Marfan Syndrome surgery primarily focuses on addressing the heart and blood vessel complications, especially related to the aorta and heart valves. Doctors often recommend surgery to prevent life-threatening events like aortic dissection or rupture. Common procedures include aortic replacement, aortic valve repair, or replacement of the mitral valve.
Non-functional mutation in the FBN1 (Fibrillin 1) primarily causes Marfan Syndrome. This gene provides information for making the protein fibrillin-1. It is a crucial component of microfibrils, which are essential for the structure and elasticity of connective tissues throughout the body.
Marfan Syndrome can affect individuals of any age, from infancy to adulthood, but many cases occur during childhood or adolescence. After diagnosis, some individuals may show symptoms shortly after birth, while others may not exhibit noticeable symptoms until later in life. The median age of diagnosis is around 19 years old, but it can range from early infancy to the 70s.
There is no availability of commercially approved gene therapy for treating Marfan Syndrome. However, research into gene therapy is ongoing and may show promising results. Researchers are exploring gene therapy as a potential treatment for the aortic complications associated with Marfan Syndrome.
If you do not treat Marfan Syndrome condition properly, it can lead to severe and potentially life-threatening complications. The most serious complications involve the heart and blood vessels, particularly the aorta. Aortic aneurysms and dissections are major risks and, without treatment, can lead to rupture or death. Additionally, it can cause vision problems, skeletal abnormalities, and other health issues.
A thorough consultation with a cardiologist or a cardiac surgeon is crucial to determine the most appropriate treatment plan and receive a cost estimate. Additionally, research hospitals known for their expertise in Marfan Syndrome and cardiac surgery, and compare their prices.